This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BG Medicine To Present At The 31st Annual Cowen Health Care Conference On March 8, 2011

WALTHAM, Mass., March 4, 2011 (GLOBE NEWSWIRE) -- BG Medicine (Nasdaq:BGMD) today announced that it will present at the 31 st Annual Cowen Health Care Conference on Tuesday, March 8, 2011 at 9:30 am EST. Pieter Muntendam, MD, President and Chief Executive Officer of BG Medicine will present on the company's behalf. The presentation will be available to the public through a webcast accessible via http://www.wsw.com/webcast/cowen3/bgmd/ or in the "Investors" section of the Company's website at www.bg-medicine.com. A replay of the presentation will be available on the company's website for 30 days.

About BG Medicine

BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. BG Medicine recently launched the galectin-3 test for use in patients with heart failure.  The galectin-3 test is the first novel blood test for cardiac disease cleared by the FDA in five years. For additional information about BG Medicine and galectin-3 testing, please visit www.bg-medicine.com and www.galectin-3.com .

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8765

CONTACT: Michael W. Rogers
         EVP & Chief Financial Officer
         (781) 890-1199

company logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,802.81 -125.39 -0.70%
S&P 500 2,073.30 -16.16 -0.77%
NASDAQ 4,901.9070 -37.42 -0.76%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs